These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 9218122
21. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process. Terry R, Cheung YF, Praestegaard M, Baillie GS, Huston E, Gall I, Adams DR, Houslay MD. Cell Signal; 2003 Oct; 15(10):955-71. PubMed ID: 12873709 [Abstract] [Full Text] [Related]
26. Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of Mesocestoides corti-infected BALB/c mice by phosphodiesterase 4 inhibitors. Souness JE, Houghton C, Sardar N, Withnall MT. Biochem Pharmacol; 1999 Sep 15; 58(6):991-9. PubMed ID: 10509751 [Abstract] [Full Text] [Related]
27. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus. Suvarna NU, O'Donnell JM. J Pharmacol Exp Ther; 2002 Jul 15; 302(1):249-56. PubMed ID: 12065724 [Abstract] [Full Text] [Related]
29. Characterization of CHO-K1 cells stably expressing PDE-IV enzymes. Whole-cell cAMP determinations vs broken-cell enzymatic assays. Pon DJ, Plant M, Tkach J, Boulet L, Muise E, Allen RA, Rodger IW. Cell Biochem Biophys; 1998 Jul 15; 29(1-2):159-78. PubMed ID: 9631244 [Abstract] [Full Text] [Related]
30. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633. Cohan VL, Showell HJ, Fisher DA, Pazoles CJ, Watson JW, Turner CR, Cheng JB. J Pharmacol Exp Ther; 1996 Sep 15; 278(3):1356-61. PubMed ID: 8819523 [Abstract] [Full Text] [Related]
31. A comparison of the inhibitory activity of selective PDE4 inhibitors on eosinophil recruitment in guinea pig skin. Teixeira MM, Miotla JM, Cooper N, Gristwood RW, Hellewell PG. Mem Inst Oswaldo Cruz; 1997 Sep 15; 92 Suppl 2():193-6. PubMed ID: 9698932 [Abstract] [Full Text] [Related]
32. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4). Thompson WJ, Ashikaga T, Kelly JJ, Liu L, Zhu B, Vemavarapu L, Strada SJ. Biochem Pharmacol; 2002 Feb 15; 63(4):797-807. PubMed ID: 11992650 [Abstract] [Full Text] [Related]
35. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram. Michie AM, Lobban M, Müller T, Harnett MM, Houslay MD. Cell Signal; 1996 Feb 15; 8(2):97-110. PubMed ID: 8730511 [Abstract] [Full Text] [Related]